Background Frequent use of antibiotics in patients with COVID-19 threatens to exacerbate
antimicrobial resistance. We aimed to establish the prevalence and predictors of bacterial …

Abstracts Coronavirus disease 2019 (COVID-19) emerged as a pandemic that spread
rapidly around the world, causing nearly 500 billion infections and more than 6 million …

Objectives We described the current incidence and risk factors of bacterial co-infection in
hospitalized patients with COVID-19. Methods Observational cohort study was performed at …

In recent years, personalized or precision medicine has made effective inroads into the
management of diseases, including respiratory diseases. The route to implementing this …

Introduction We evaluated the prevalence, aetiologies and antibiotic resistance patterns of
bacterial infections in hospitalized patients with laboratory-confirmed SARS-CoV-2. We also …

Secondary bacterial infection in COVID-19 patients is associated with increased mortality
and disproportionately affects critically ill patients. This single-centre retrospective …

This review aims to summarize current progress in the management of critically ill, using
biomarkers as guidance for antimicrobial treatment with a focus on antimicrobial …

The intricate interplay between oral microbiota and the human host extends beyond the
confines of the oral cavity, profoundly impacting the general health status. Both periodontal …

This statement addresses the inappropriate antibiotic prescribing occurring during the
coronavirus 2019 pandemic (COVID-19) that has exacerbated another urgent public health …

Objectives To assess the ability of procalcitonin (PCT)—a promising marker for coinfections—
to predict coinfections in patients with COVID-19. Methods In this systematic review and …